Acme United Corporation remains a solid 'Buy' as shares have outperformed the S&P 500, rising 15.5% since November. ACU's Q1 2026 revenue rose to $52.3 million, driven by the My Medic acquisition and robust organic growth, especially in Europe and Canada. Despite top-line growth, ACU's net income fell from $1.7 million to $1 million, pressured by tariffs and inventory build-up amid geopolitical uncertainty.
Here is how Acme United Corporation. (ACU) and ASICS Corporation Unsponsored ADR (ASCCY) have performed compared to their sector so far this year.
Acme United Corporation (ACU) Q1 2026 Earnings Call Transcript
Acme United Corporation. (ACU) came out with quarterly earnings of $0.24 per share, missing the Zacks Consensus Estimate of $0.55 per share.
Here is how Acme United Corporation. (ACU) and ASICS Corporation Unsponsored ADR (ASCCY) have performed compared to their sector so far this year.
Acme United (ACU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here is how Acme United Corporation. (ACU) and Carter's (CRI) have performed compared to their sector so far this year.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here is how Acme United Corporation. (ACU) and Carter's (CRI) have performed compared to their sector so far this year.
Acme United (ACU) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Acme United Corporation. (ACU) came out with quarterly earnings of $0.46 per share, in line with the Zacks Consensus Estimate.
Acme United Corporation (ACU) remains a 'buy', despite recent underperformance, trading at attractive absolute valuations, and overlooked, due to its small market cap. ACU's latest results show modest revenue growth, strong international performance, but mixed profitability, due to tariffs and increased promotional spending in the US. Management is investing in growth, including facility expansions and product line enhancements, while maintaining low leverage and focusing on cost controls.